Cambridge Investment Research Advisors’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VXX
CCS
JF
TA
JC
Cambridge Investment Research Advisors's VXX Position: Q4 2025 in Review
Cambridge Investment Research Advisors sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q4 2025, closing a stake of 10,157 shares — an estimated $337K sold.
Cambridge Investment Research Advisors first reported a position in VXX in Q3 2019 and held it in 14 quarters. The position peaked at $1.61M in Q3 2020. 73 funds tracked by Wall St. Rank hold VXX as of Q4 2025.
- Cambridge Investment Research Advisors reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q4 2025 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 10,157 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q4 2025, an estimated $337K.
- Cambridge Investment Research Advisors first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019 and held it in 14 quarters.
- Cambridge Investment Research Advisors's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $1.61M in Q3 2020.
- 73 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q4 2025.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.